JyotiMalhotraMD

PubMed

• Management of-mutated non-small cell lung cancer.
  Semeniuk Iii, G., Malhotra, J., Nguyen, D., Tan, T.> ;Clinical Advances in Hematology & Oncology. 2024 Mar 1
• Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosin...
  Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying Du> ;Journal of Thoracic Disease. 2023 Oct 31
• A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer.
  Prakash Kulkarni, Atish Mohanty, Sravani Ramisetty, Herbert Duvivier, Ajaz Khan, Sagun Shrestha, Tingting Tan, Amartej Merla, Michelle El-Hajjaoui, Jyoti Malhotra, Sha...> ;Biomolecules. 2023 Oct 28
• 1 citations
  Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience.
  Miguel A Villalona-Calero, Jyoti Malhotra, Vincent Chung, Yan Xing, Stacy W Gray, Heather Hampel, Stephen Gruber, Kevin McDonnell> ;Journal of Clinical Medicine. 2023 Jun 15
• Pneumonitis in advanced non-small cell lung cancer: no interaction between immune checkpoint inhibition and radiation therapy.
  Shane S Neibart, Jyoti Malhotra, Jason A Roy, Brian L Strom, Salma K Jabbour> ;Journal of Thoracic Disease. 2023 May 30
• 1 citations
  A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
  Spencer, K., Portal, D., Aisner, J., Stein, M., Malhotra, J., Shih, W., Chan, N., Silk, A., Ganesan, S., Goodin, S., Gounder, M., Lin, H., Li, J., Cerchio, R., Marinar...> ;Oncotarget. 2023 Apr 10
• 14 citations
  Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors.
  Vrushank Bhatt, Taijin Lan, Wenping Wang, Jerry Kong, Eduardo Cararo Lopes, Jianming Wang, Khoosheh Khayati, Akash Raju, Michael Rangel, Enrique Lopez, Zhixian Sherrie...> ;Cell Death & Disease. 2023 Jan 26
• 8 citations
  A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer.
  Sravani Ramisetty, Prakash Kulkarni, Supriyo Bhattacharya, Arin Nam, Sharad S Singhal, Linlin Guo, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti Malh...> ;Journal of Clinical Medicine. 2023 Jan 11
• 5 citations
  Oncolytic Viruses and Cancer Immunotherapy.
  Jyoti Malhotra, Edward S Kim> ;Current Oncology Reports. 2023 Jan 1
• 5 citations
  Addressing Drug Resistance in Cancer: A Team Medicine Approach.
  Prakash Kulkarni, Atish Mohanty, Supriyo Bhattacharya, Sharad Singhal, Linlin Guo, Sravani Ramisetty, Tamara Mirzapoiazova, Bolot Mambetsariev, Sandeep Mittan, Jyoti M...> ;Journal of Clinical Medicine. 2022 Sep 27
• 6 citations
  A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tu...
  Ann W Silk, Biren Saraiya, Roman Groisberg, Nancy Chan, Kristen Spencer, Eugenia Girda, Weichung Shih, Marisa Palmeri, Tracie Saunders, Robert M Berman, Vlad Coric, Su...> ;European Journal of Medical Research. 2022 Jul 2
• Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma.
  Gina M Castellano, Saman Zeeshan, Olga B Garbuzenko, Hatim E Sabaawy, Jyoti Malhotra, Tamara Minko, Sharon R Pine> ;Molecular Cancer Therapeutics. 2022 Sep 6
• 6 citations
  Clinical outcomes and immune phenotypes associated withco-occurring mutations in non-small cell lung cancer.
  Jyoti Malhotra, Brid Ryan, Malini Patel, Nancy Chan, Yanxiang Guo, Joseph Aisner, Salma K Jabbour, Sharon Pine> ;Journal of Thoracic Disease. 2022 Jun 1
• 7 citations
  A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).
  Ticiana A Leal, Marina N Sharifi, Nancy Chan, Robert Wesolowski, Anita A Turk, Justine Y Bruce, Ruth M O'Regan, Jens Eickhoff, Lisa M Barroilhet, Jyoti Malhotra, Janic...> ;Cancer Medicine. 2022 Nov 1
• 3 citations
  Racial disparities in follow-up care of early-stage lung cancer survivors.
  Jyoti Malhotra, Lisa E Paddock, Yong Lin, Sharon R Pine, Muhammad H Habib, Antoinette Stroup, Sharon Manne> ;Journal of Cancer Survivorship. 2023 Oct 1
• 6 citations
  The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating-target genes.
  Xi-Yang Tang, Yan-Lu Xiong, An-Ping Shi, Ying Sun, Qing Han, Yao Lv, Xian-Gui Shi, Milo Frattini, Jyoti Malhotra, Kai-Fu Zheng, Yu-Jian Liu, Tao Jiang, Nan Ma, Jin-Bo ...> ;Translational Lung Cancer Research. 2022 Mar 1
• 89 citations
  Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
  M Palmeri, J Mehnert, A W Silk, S K Jabbour, S Ganesan, P Popli, G Riedlinger, R Stephenson, A B de Meritens, A Leiser, T Mayer, N Chan, K Spencer, E Girda, J Malhotra...> ;ESMO Open. 2022 Feb 1
• 1 citations
  Use of tumor cell lysate to develop peptide vaccine targeting cancer-testis antigens
  Jyoti Malhotra, Janice M. Mehnert> ;Translational Lung Cancer Research. 2021 Dec 1
• 1 citations
  A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
  Antoinette R. Tan, Nancy Chan, Brian F. Kiesel, Mark N. Stein, Rebecca A. Moss, Jyoti Malhotra, Joseph Aisner, Mansi Shah, Murugesan Gounder, Hongxia Lin, Michael P. K...> ;Cancer Chemotherapy and Pharmacology. 2021 Oct 20
• 1 citations
  Validation of a claims-based algorithm for identifying non-infectious pneumonitis in patients diagnosed with lung cancer.
  Shane S. Neibart, Jyoti Malhotra, Salma K. Jabbour, Jason Roy, Brian L. Strom> ;Pharmacoepidemiology and Drug Safety. 2021 Aug 11
• 1 citations
  Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-sm...
  Matthew P. Deek, Nikhil Yegya-Raman, Parima Daroui, S. Balasubramanian, Jyoti Malhotra, Dirk F. Moore, Malini Patel, Shang-Jui Wang, Joseph Aisner, Salma K. Jabbour> ;Annals of Palliative Medicine. 2021 Jun 26
• 6 citations
  Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).
  Saad A. Khan, Z. Sun, Suzanne E. Dahlberg, Jyoti Malhotra, Roger Keresztes, Chukwuemeka Ikpeazu, Patrick Ma, Suresh S. Ramalingam, Rathi N. Pillai> ;JTO Clinical and Research Reports. 2021 May 1
• 6 citations
  Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development.
  Jinghan Shi, Fujun Yang, Nanfeng Zhou, Yan Jiang, Yanfeng Zhao, Junjie Zhu, Arsela Prelaj, Jyoti Malhotra, Nicola Normanno, Elisa Danese, Andrés F. Cardona, Xuan Hong,...> ;Translational Lung Cancer Research. 2021 Mar 1
• 34 citations
  A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
  Jyoti Malhotra, Petros Nikolinakos, Ticiana Leal, Jonathan M. Lehman, Daniel Morgensztern, Jyoti D. Patel, John Wrangle, Giuseppe Curigliano, Laurent Greillier, Meliss...> ;Journal of Thoracic Oncology. 2021 Feb 27
• 43 citations
  Montelukast in hospitalized patients diagnosed with COVID-19.
  Ahsan R. Khan, Christian Misdary, Nikhil Yegya-Raman, Sinae Kim, Navaneeth Narayanan, Sheraz Siddiqui, Padmini Salgame, Jared Radbel, Frank De Groote, Carl Michel, Jan...> ;The Journal of Asthma. 2021 Mar 4
• Join now to see all

Lectures

• Ph1/2 study of Rova-T in combination with nivolumab (Nivo) ± ipilimumab (Ipi) for patients (pts) with 2L+ extensive-stage (ED) SCLC. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019